FDA Approves Zephyr Endobronchial Valve for Treating Severe Emphysema

  • Posted by Chris Kellett
  • On June 29, 2018
REDWOOD CITY, Calif. – June 29, 2018 – Pulmonx® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the first minimally-invasive device approved in the United States for
Read More